FDA approves first nasal spray flu vaccine for use at home
FluMist is the only nasal flu vaccine, but it is not new. The FDA approved it in 2003 for people 5 to 49 years old before expanding eligibility in 2007 to children as young as 2 years old — requiring in both instances that it be administered by a vaccine provider.
There hasn’t been a new class of drugs approved to help smokers quit since Pfizer's Chantix reached the market nearly two ...
Less than a year after snagging its first FDA approval in psoriasis, UCB’s blockbuster hopeful Bimzelx has picked up three more indications to add to its growing resume of inflammatory disease ...
The FDA's Center for Veterinary Medicine (CVM) announced Smiths Medical’s recall of the PneuPAC paraPAC Plus P300 and ...
The Food and Drug Administration had recently approved a new drug for the treatment of atopic dermatitis (eczema), which can significantly improve symptoms.
The snacks now have a Class I risk level, meaning there is a "reasonable probability" they could cause "serious adverse ...
The US Food and Drug Administration (FDA) has issued 510(k) clearance to See-Mode Technologies for their AI-based thyroid ...
The Food and Drug Administration sends warning letters to entities under its jurisdiction as part of its enforcement activities. Some letters are not ...
Investing News Network on MSN3d
FDA Finds Kratom Capsules Safe, but Questions About Concentrated Forms RemainThe FDA study involved 40 participants divided into five groups, each receiving either a placebo or escalating doses of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback